Chunping Zhang Selected Research

Purinergic P2X3 Receptors

11/2019	Corrigendum to "Role of P2X3 receptor in myocardial ischemia injury and nociceptive sensory transmission" [Auton. Neurosci.: Basic Clin. volume 139, (issues 1-2), (30 May 2008), pages 30-37].
9/2019	Correction to: lncRNA NONRATT021972 siRNA Decreases Diabetic Neuropathic Pain Mediated by the P2X3 Receptor in Dorsal Root Ganglia.
12/2017	Nanoparticle-encapsulated emodin decreases diabetic neuropathic pain probably via a mechanism involving P2X3 receptor in the dorsal root ganglia.
10/2017	Effects of nanoparticle-encapsulated curcumin on HIV-gp120-associated neuropathic pain induced by the P2X3 receptor in dorsal root ganglia.
10/2017	Long noncoding RNA MRAK009713 is a novel regulator of neuropathic pain in rats.
1/2017	Erratum to: The effect of sinomenine in diabetic neuropathic pain mediated by the P2X3 receptor in dorsal root ganglia.
1/2017	The effect of sinomenine in diabetic neuropathic pain mediated by the P2X3 receptor in dorsal root ganglia.
1/2017	lncRNA NONRATT021972 siRNA Decreases Diabetic Neuropathic Pain Mediated by the P2X3 Receptor in Dorsal Root Ganglia.
1/2017	A317491 relieved HIV gp120-associated neuropathic pain involved in P2X3 receptor in dorsal root ganglia.
3/2016	LncRNA uc.48+ is involved in diabetic neuropathic pain mediated by the P2X3 receptor in the dorsal root ganglia.

For more, sign up at right for free...

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Chunping Zhang Research Topics

Disease

22	Neuralgia (Stump Neuralgia) 03/2021 - 03/2016
16	Hyperalgesia 01/2021 - 04/2016
11	Pain (Aches) 01/2022 - 01/2008
9	Myocardial Ischemia (Ischemic Heart Diseases) 07/2022 - 01/2008
5	Inflammation (Inflammations) 12/2019 - 02/2015
5	Neoplasms (Cancer) 07/2019 - 10/2017
3	Brain Ischemia (Cerebral Ischemia) 12/2019 - 02/2014
2	Ovarian Neoplasms (Ovarian Cancer) 01/2020 - 02/2018
2	Squamous Cell Carcinoma of Head and Neck 06/2019 - 01/2019
2	Type 2 Diabetes Mellitus (MODY) 12/2018 - 08/2017
2	Infections 01/2015 - 10/2008
1	Urinary Retention 01/2022
1	Substance-Related Disorders (Drug Abuse) 05/2021
1	Fatty Liver 01/2021
1	Non-alcoholic Fatty Liver Disease 01/2021
1	Polyploidy 11/2020
1	Endometriosis 07/2019
1	Polycystic Ovary Syndrome (Syndrome, Stein-Leventhal) 07/2019
1	Carcinoma (Carcinomatosis) 06/2019
1	Carcinogenesis 06/2019
1	Neoplasm Metastasis (Metastasis) 01/2019
1	Foodborne Diseases 01/2019
1	Insulin Resistance 01/2018
1	Necrosis 01/2018
1	Hemolysis 01/2018
1	Diabetes Mellitus 12/2017
1	Peripheral Nervous System Diseases (PNS Diseases) 12/2017
1	Mitochondrial Diseases (Mitochondrial Disease) 12/2017
1	Chronic Pain 09/2017
1	Hyperglycemia 08/2017
1	Wounds and Injuries (Trauma) 01/2017
1	Retinoblastoma (Glioblastoma, Retinal) 12/2016
1	Cognitive Dysfunction 09/2016
1	Treatment-Resistant Depressive Disorder 09/2016

Drug/Important Bio-Agent (IBA)

13	Small Interfering RNA (siRNA)IBA 01/2021 - 10/2014
12	Proteins (Proteins, Gene)FDA Link 01/2021 - 05/2008
12	Purinergic P2X3 ReceptorsIBA 11/2019 - 05/2008
11	Long Noncoding RNAIBA 07/2022 - 01/2016
10	Messenger RNA (mRNA)IBA 01/2019 - 01/2008
7	Purinergic P2X7 ReceptorsIBA 12/2020 - 01/2016
6	Glycoproteins (Glycoprotein)IBA 03/2021 - 10/2017
5	Adenosine Triphosphate (ATP)IBA 12/2019 - 01/2008
4	Purinergic P2X4 ReceptorsIBA 12/2019 - 09/2017
3	A-317491IBA 01/2017 - 01/2008
2	Zalcitabine (Hivid)FDA Link 03/2021 - 01/2018
2	Glucose (Dextrose)FDA LinkGeneric 01/2021 - 08/2017
2	MicroRNAs (MicroRNA)IBA 07/2019 - 06/2019
2	QuercetinIBA 06/2019 - 01/2019
2	Ion Channels (Ion Channel)IBA 01/2019 - 01/2018
2	CytokinesIBA 12/2018 - 01/2017
2	Nonesterified Fatty Acids (NEFA)IBA 01/2018 - 02/2015
2	CurcuminIBA 10/2017 - 01/2017
2	sinomenineIBA 01/2017 - 01/2017
2	Neuroprotective AgentsIBA 01/2017 - 02/2015
2	ResveratrolIBA 01/2017 - 02/2015
2	puerarinIBA 05/2014 - 02/2014
1	Carbamazepine (Tegretol)FDA LinkGeneric 05/2021
1	Endocrine DisruptorsIBA 01/2021
1	LipidsIBA 01/2021
1	bisphenol AIBA 01/2021
1	OligonucleotidesIBA 11/2020
1	Pharmaceutical PreparationsIBA 01/2020
1	CateninsIBA 06/2019
1	Adenosine Diphosphate (ADP)IBA 01/2019
1	Angiogenesis InhibitorsIBA 01/2019
1	p38 Mitogen-Activated Protein KinasesIBA 01/2019
1	licochalcone AIBA 01/2019
1	Guan-fu base AIBA 01/2019
1	FluoroquinolonesIBA 01/2019
1	Tumor Necrosis Factor Receptors (Tumor Necrosis Factor Receptor)IBA 12/2018
1	Inhibins (Inhibin)IBA 02/2018
1	Estrogens (Estrogen)FDA Link 02/2018
1	Hormones (Hormone)IBA 02/2018
1	baicalinIBA 01/2018
1	Hemolysin Proteins (Hemolysins)IBA 01/2018
1	Virulence Factors (Pathogenicity Factors)IBA 01/2018
1	Glial Fibrillary Acidic ProteinIBA 01/2018
1	Interleukin-1beta (Interleukin 1 beta)IBA 01/2018
1	Interleukin-10 (Interleukin 10)IBA 01/2018
1	Brain-Derived Neurotrophic Factor (BDNF)IBA 01/2018
1	Amino Acids FDA Link 01/2018
1	andrographolideIBA 01/2018
1	salicylhydroxamic acid (SHAM)IBA 01/2018
1	3- (5- (2,3- dichlorophenyl)- 1H- tetrazol- 1- yl)methylpyridineIBA 01/2018
1	osthol (osthole)IBA 01/2018
1	Mitochondrial Permeability Transition PoreIBA 12/2017
1	Emodin (Archin)IBA 12/2017
1	NAD (NADH)IBA 12/2017
1	coomassie Brilliant BlueIBA 10/2017
1	artemisinin (artemisinine)IBA 09/2017
1	Fatty Acids (Saturated Fatty Acids)IBA 08/2017
1	GlucokinaseIBA 08/2017
1	Glycogen Synthase (Synthase I)IBA 08/2017
1	Connexin 43 (Connexin43)IBA 01/2017
1	Ketamine FDA LinkGeneric 09/2016

Therapy/Procedure

2	Therapeutics 12/2019 - 09/2017
1	Indwelling Catheters (Indwelling Catheter) 01/2022
1	Acupuncture Points (Acupuncture Point) 01/2022
1	Drug Therapy (Chemotherapy) 01/2020
1	Highly Active Antiretroviral Therapy (HAART) 01/2018